2021
DOI: 10.1038/s41598-021-99007-3
|View full text |Cite
|
Sign up to set email alerts
|

Powerful use of automated prioritization of candidate variants in genetic hearing loss with extreme etiologic heterogeneity

Abstract: Variant prioritization of exome sequencing (ES) data for molecular diagnosis of sensorineural hearing loss (SNHL) with extreme etiologic heterogeneity poses a significant challenge. This study used an automated variant prioritization system (“EVIDENCE”) to analyze SNHL patient data and assess its diagnostic accuracy. We performed ES of 263 probands manifesting mild to moderate or higher degrees of SNHL. Candidate variants were classified according to the 2015 American College of Medical Genetics guidelines, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…However, in a clinical setting, trio testing would not be feasible due to the increased costs of parental WES and the possibility that parental DNA is not available. In addition, the curating times and costs of WES analysis were reduced due to automatic variant interpretation by EVIDENCE (Seo et al 2020 ; Kim et al 2021 ), thus suggesting that proband-only WES by EVIDENCE is a comparable diagnostic approach for these patients in a routine clinical setting.…”
Section: Discussionmentioning
confidence: 99%
“…However, in a clinical setting, trio testing would not be feasible due to the increased costs of parental WES and the possibility that parental DNA is not available. In addition, the curating times and costs of WES analysis were reduced due to automatic variant interpretation by EVIDENCE (Seo et al 2020 ; Kim et al 2021 ), thus suggesting that proband-only WES by EVIDENCE is a comparable diagnostic approach for these patients in a routine clinical setting.…”
Section: Discussionmentioning
confidence: 99%